Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: Results of the ACRIN 6668/RTOG 0235 trial

Mitchell Machtay, Fenghai Duan, Barry A. Siegel, Bradley S. Snyder, Jeremy J. Gorelick, Janet S. Reddin, Reginald Munden, Douglas W. Johnson, Larry H. Wilf, Albert DeNittis, Nancy Sherwin, Kwan Ho Cho, Seok Ki Kim, Gregory Videtic, Donald R. Neumann, Ritsuko Komaki, Homer Macapinlac, Jeffrey D. Bradley, Abass Alavi

Research output: Contribution to journalArticlepeer-review

135 Scopus citations

Fingerprint

Dive into the research topics of 'Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: Results of the ACRIN 6668/RTOG 0235 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences